s6y

ACCENTIA BIOPHARMACEUTICALS INC

CIK
1310094
Industry
Pharmaceutical Preparations

Financials 36

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2013
  2. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2013
  3. 10-Q Quarterly Report for period ending Dec 31, 2012
  4. 10-K Annual Report for period ending Sep 30, 2012
  5. 10-Q Quarterly Report for period ending Jun 30, 2012
  6. 10-Q Quarterly Report for period ending Mar 31, 2012
  7. 10-Q Quarterly Report for period ending Dec 31, 2011
  8. 10-K Annual Report for period ending Sep 30, 2011
  9. 10-Q Quarterly Report for period ending Jun 30, 2011
  10. 10-Q Quarterly Report for period ending Mar 31, 2011

All 36 financials filings

News 124

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K/A Current report filing
  10. 8-K Current report filing

All 124 news filings

Ownership 142

  1. SC 13G/A Major Shareholders
  2. SC 13G Major Shareholders
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 142 ownership filings

Prospectus 145

  1. RW Registration Withdrawal Request
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-1/A General form of registration statement for all companies including face-amount certificate companies
  7. S-1 General form of registration statement for all companies including face-amount certificate companies
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-1 General form of registration statement for all companies including face-amount certificate companies

All 145 prospectus filings

Proxies 12

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. PRER14A Preliminary revised proxy soliciting materials
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEF 14A Definitive proxy statements

All 12 proxies filings

Other 91

  1. REVOKED
  2. EFFECT Notice of Effectiveness
  3. D Exempt (Private) Offering
  4. EFFECT Notice of Effectiveness
  5. UPLOAD Letter (PDF)
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. UPLOAD Letter (PDF)
  8. D Exempt (Private) Offering
  9. CT ORDER Order Granting Confidential Treatment
  10. UPLOAD Letter (PDF)

All 91 other filings